Debra MD - LianBio ADR Pres Officer

LIANDelisted Stock  USD 2.18  0.05  2.24%   

Insider

Debra MD is Pres Officer of LianBio ADR
Age 59
Phone609 486 2308
Webhttps://www.lianbio.com

LianBio ADR Management Efficiency

The company has return on total asset (ROA) of (0.2167) % which means that it has lost $0.2167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3242) %, meaning that it created substantial loss on money invested by shareholders. LianBio ADR's management efficiency ratios could be used to measure how well LianBio ADR manages its routine affairs as well as how well it operates its assets and liabilities.
LianBio ADR currently holds 4.34 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. LianBio ADR has a current ratio of 15.49, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about LianBio ADR's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

BSc FRCPathAchilles Therapeutics PLC
59
Timothy MayerNextCure
59
Jeffrey BornsteinEledon Pharmaceuticals
N/A
Julie MBADay One Biopharmaceuticals
42
Michele AndersonAssembly Biosciences
N/A
MA MSInozyme Pharma
N/A
Mark MeierFennec Pharmaceuticals
N/A
Kerry WentworthNuvation Bio
51
Jaa RobersonDay One Biopharmaceuticals
N/A
Sergey YurasovNuvation Bio
51
Charles IIDay One Biopharmaceuticals
47
Michelle DoigNuvation Bio
46
Iraj AliAchilles Therapeutics PLC
49
David HanleyNuvation Bio
54
Christine MBAHookipa Pharma
59
Gary MDVerrica Pharmaceuticals
47
Gary HattersleyNuvation Bio
57
Senthil SundaramTerns Pharmaceuticals
46
Julie BockenstetteAcumen Pharmaceuticals
N/A
Julia WilsonAchilles Therapeutics PLC
N/A
PharmD ChiodinDay One Biopharmaceuticals
N/A
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. Lianbio ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. LianBio ADR (LIAN) is traded on NASDAQ Exchange in USA and employs 163 people.

Management Performance

LianBio ADR Leadership Team

Elected by the shareholders, the LianBio ADR's board of directors comprises two types of representatives: LianBio ADR inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LianBio. The board's role is to monitor LianBio ADR's management team and ensure that shareholders' interests are well served. LianBio ADR's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LianBio ADR's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jiang Qian, China Mang
Konstantin Poukalov, Founder Chairman
Ji Chen, Senior Counsel
Debra MD, Pres Officer
Levvy Eng, Senior Development
Adam Stone, Interim Director
Ehong Gu, VP CFO
Yizhe Wang, CEO Director
Yi MBA, CFO Treasurer
Michael MD, Chief Advisor
Brianne Jahn, Chief Officer

LianBio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LianBio ADR a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with LianBio ADR

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LianBio ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will appreciate offsetting losses from the drop in the long position's value.

Moving against LianBio Stock

  0.35MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.34MSFT MicrosoftPairCorr
  0.32BKRKF PT Bank RakyatPairCorr
The ability to find closely correlated positions to LianBio ADR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LianBio ADR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LianBio ADR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LianBio ADR to buy it.
The correlation of LianBio ADR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LianBio ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LianBio ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LianBio ADR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated